Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2025-12-25 @ 5:27 PM
Study NCT ID:
NCT03849404
Status:
COMPLETED
Last Update Posted:
2020-07-28
First Post:
2019-02-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis
Sponsor:
Alvotech Swiss AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-20
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-20
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-05
First Submit QC Date:
None
Study First Post Date:
2019-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-27
Last Update Post Date:
2020-07-28
Last Update Post Date Type:
ACTUAL